ERIKA VALTINSON: Open Payments
NPI 1770760118 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 25 payments from 11 companies in 2025. Trend: 2023 $563 · 2024 $1,281 · 2025 $1,104
Food & beverage: $1,104
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $389 |
| Abbott Laboratories | 2 | $220 |
| Kestra Medical Technology Services, Inc. | 2 | $159 |
| Novo Nordisk Inc | 2 | $139 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Amgen Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
Products named: FARAPULSE, ENSITE, Assure WCD, Ozempic, WATCHMAN FLX, AGILIS, FARXIGA, REPATHA.
Industry payments across ID — which companies pay providers there.
